Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 15287915

ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Haematol
Publication date
2004 Sep
First author
Jerkeman M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Jerkeman M
      type
      Author
    2. name
      Leppä S
      type
      Author
    3. name
      Kvaløy S
      type
      Author
    4. name
      Holte H
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Jerkeman M
      type
      Author
    2. name
      Leppä S
      type
      Author
    3. name
      Kvaløy S
      type
      Author
    4. name
      Holte H
      type
      Author
    bibliography ids
    1. nci-bib-06b2ff54290d5cd7e0672d55
    book metadata
    content sha256
    3664bbdca9ebd30a9767b38008d56e0e014218f3e19f5454024f20f5c88c5131
    document type
    citation
    dois
    1. 10.1111/j.1600-0609.2004.00294.x
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:15287915
    immutable id
    pubmed:15287915@3664bbdca9ebd30a9767b38008d56e0e014218f3e19f5454024f20f5c88c5131
    journal
    abbreviation
    Eur J Haematol
    issn electronic
    Source null
    issn print
    0902-4441
    issue
    3
    name
    European journal of haematology
    nlm unique id
    8703985
    pages
    179-82
    volume
    73
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      15287915
      provenance
      batch id
      748437a772c9631ad901
      provider
      NCBI PubMed ESummary
      record sha256
      607eba0aa32dda008dad19df0460f8c9ba745e1135b7439a8a241d1d9a253e70
      response sha256
      1535c16de1ca2ef53b01ccf9e7709049035aa1b159955f06fbec3d1a0daddc80
      retrieved at
      2026-09-09T23:45:55.399079+00:00
      publication date
      display
      2004 Sep
      precision
      month
      year
      2004
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/15287915/
      title
      ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.

      Preserved source evidence · Independent clinical review pending · Not medical advice